Prevalence of Dyslipidemia in HIV-Positive Women with HPV Coinfection: A Preliminary Study
Table 3
Laboratory results of HIV-positive women with and without HPV coinfection, São Luís, Maranhão, Brazil, 2018–2019.
HPV-positive N = 41
HPV-negative N = 41
value
Glucose fasting
87.13 ± 14.37
84.84 ± 11.46
0.36
Insulin
9.39 ± 8.47
9.8 ± 7.33
0.85
Homa-IR
2.09 ± 2.29
2.14 ± 1.85
0.9
TyG
8.60 ± 0.54
8.43 ± 1.15
0.41
Total cholesterol
195 ± 41.34
171 ± 52.08
0.04
Triglycerides
139.2 ± 73.41
138.28 ± 71.23
0.95
HDL-C
42.31 ± 13.26
44.44 ± 15.40
0.54
LDL-C
118.39 ± 35.77
98.2 ± 38.36
0.03
Non-HDL-C
119 ± 54.9
143 ± 44.5
0.04
Castelli index I
4.7 ± 1.41
4.00 ± 0.77
0.04
Castelli index II
2.89 ± 1.09
2.34 ± 0.66
0.04
Plasma atherogenic index
0.5 ± 0.25
0.49 ± 0.25
0.8
Atherogenic coefficient
2.99 ± 0.75
3.64 ± 1.38
0.03
Data are presented as mean ± standard deviation. Tests used: Student’s t-test. Abbreviations: TyG: relationship between triglycerides and glycemia; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; and non-HDL-C: not high-density lipoprotein cholesterol. Source: elaborated by the authors, 2020.
